Yoga to Reduce Cancer Fatigue

University of Iowa

Status and phase

Completed

Phase 2

Conditions

Breast Neoplasm

Treatments

Behavioral: Yoga

Study type

Interventional

Funder types

Other

Identifiers

NCT00583739

200707733

Details and patient eligibility

About

A randomized trial from the British National Health Service found that supervised exercise benefits women with early stage breast cancer with improved functional and psychological benefit after a 12-week intervention and 6 months later. Considering the needs of breast cancer patients and survivors and the reported benefits of exercise and yoga intervention, the investigators propose a pilot study of an 8-week yoga intervention in breast cancer patients. This study would specifically address measures of fatigue and psychosocial distress in the population of breast cancer patients during treatment and within the year following treatment. Currently there is very limited literature on yoga intervention in this population.

Enrollment

66 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Potential subjects must have had histologically or cytologically confirmed breast cancer. This includes, but is not limited to: breast cancer-in situ; ductal carcinoma in situ; lobular carcinoma in situ; cystosarcoma phyllodes; inflammatory breast carcinoma; invasive breast carcinoma; and breast cancer not otherwise specified; cancer must be stage 0 through stage III.
Treatment completion within the past calendar year.
Age ≥ 18 years. While breast cancer can occur in the pediatric population, the pediatric population is best served by trials specifically designed for their age group.
Life expectancy of greater than 1 year.
Karnofsky ≥ 60%; see Appendix A.
Women of childbearing potential are eligible for this study.
Pregnant women are eligible for this study pending a doctor's note.
The ability to understand and complete the study questionnaires.
Ability to understand and the willingness to sign a written informed consent document.

Exclusion criteria

Patients who have not recovered from adverse events due to agents administered more than 4 weeks earlier.
Patients with known metastasis.
Patients who are actively participating in a yoga class.
Known uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would compromise subject health during yoga.